Glenn Gormley

Glenn J.
Gormley is currently Director at Ambit Biosciences Corp.
since 2014, Independent Outside Director at Healios KK since 2022, Director at Pharmaceutical Research & Manufacturers of America, Director at Healios N.A., Inc. since 2022, Independent Director at Aktis Oncology, Inc. starting 2026, and Trustee at the University of Delaware.
Former positions include President & Chief Executive Officer at Gemin X Pharmaceuticals US, Inc., Director at Biotechnology Innovation Organization, Vice President & Head-Clinical Development at Merck & Co., Inc., Chief Medical Officer at AstraZeneca PLC, Head-Global Clinical Development at Novartis, Inc., Senior Managing Executive Officer, Head-R&D at Daiichi Sankyo Co., Ltd. from 2014 to 2019, and Chief Science Officer at Daiichi Sankyo, Inc. from 2011 to 2013.
Education includes a doctorate from The University of Chicago.